Sovereign Pharms Drug Patent Portfolio
Sovereign Pharms owns 1 orange book drug protected by 3 US patents Given below is the list of Sovereign Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10105324 | Immediate release oral guaifenesin solution | 13 Nov, 2035 | Active |
| US9549907 | Immediate release oral guaifenesin solution | 13 Nov, 2035 | Active |
| US9808431 | Immediate release oral guaifenesin solution | 13 Nov, 2035 | Active |
Latest Legal Activities on Sovereign Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Sovereign Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 10 Jul, 2024 | US9549907 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 03 May, 2024 | US9549907 |
|
Email Notification
Critical
| 03 Aug, 2022 | US10105324 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 Aug, 2022 | US9808431 |
|
Email Notification
Critical
| 03 Aug, 2022 | US9549907 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 Aug, 2022 | US9549907 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 Aug, 2022 | US10105324 |
|
Email Notification
Critical
| 03 Aug, 2022 | US9808431 |
|
Correspondence Address Change
Critical
| 01 Aug, 2022 | US10105324 |
|
Correspondence Address Change
Critical
| 01 Aug, 2022 | US9549907 |
|
Correspondence Address Change
Critical
| 01 Aug, 2022 | US9808431 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 06 Apr, 2022 | US10105324 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 04 May, 2021 | US9808431 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 22 Jul, 2020 | US9549907 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 23 Oct, 2018 | US10105324 |
Sovereign Pharms's Family Patents
Sovereign Pharms Drug List
Given below is the complete list of Sovereign Pharms's drugs and the patents protecting them.
1. Obredon
Obredon is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10105324 | Immediate release oral guaifenesin solution |
13 Nov, 2035
(10 years from now)
| Active |
| US9549907 | Immediate release oral guaifenesin solution |
13 Nov, 2035
(10 years from now)
| Active |
| US9808431 | Immediate release oral guaifenesin solution |
13 Nov, 2035
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Obredon's drug page